Figure 1.

Schema to show how participants were selected for the consent study. Of the 106 Immunology Study visits ("phlebotomy clinics") scheduled for the study period, 32 were selected through systematic sampling. A total of 481 participants enrolled for the Immunology Study during the corresponding period. Of these, 202 were eligible to participate in the consent study. Eventually, 192 participants completed the consent study questionnaire.